Additionally, the article mentions significant funding rounds for Tenvie Therapeutics, Timberlyne Therapeutics, Inari, Hippocratic AI, Evergreen Nephrology, and Ouro Medicines, all raising between $120 million and $200 million. The biggest global deal outside the U.S. was London-based Verdiva Bio's $411 million Series A for obesity and cardiometabolic treatments. The data is sourced from the Crunchbase database, tracking U.S.-based companies' funding rounds for the specified week.
Key takeaways:
- Biotech and healthcare startups dominated the top funding rounds, with several companies raising significant amounts.
- DDN, a data storage company, received the largest funding round of $300 million from Blackstone Group.
- Innovaccer, a healthcare AI solutions provider, raised $275 million, highlighting the intersection of AI and healthcare.
- The biggest global deal outside the U.S. was a $411 million Series A raised by London-based Verdiva Bio, a biotech firm.